A combined low-density lipoprotein apheresis and prednisone therapy for steroid-resistant primary focal segmental glomerulosclerosis in children-Reference-Cited by-同舟云学术

A combined low-density lipoprotein apheresis and prednisone therapy for steroid-resistant primary focal segmental glomerulosclerosis in children

Published:2003-12 Issue:6 Volume:42 Page:1121-1130
ISSN:0272-6386
Container-title:American Journal of Kidney Diseases
language:en
Short-container-title:American Journal of Kidney Diseases

Author:

Hattori Motoshi,Chikamoto Hiroko,Akioka Yuko,Nakakura Hyogo,Ogino Daisuke,Matsunaga Akira,Fukazawa Akira,Miyakawa Sanpei,Khono Miyuki,Kawaguchi Hiroshi,Ito Katsumi

Publisher

Elsevier BV

Subject

Nephrology

Reference41 articles.

1. Primary focal segmental glomerulosclerosis;Korbet;J Am Soc Nephrol,1998

2. Primary focal segmental glomerulosclerosis;Korbet;Am J Kidney Dis,1994

3. Treatment of the idiopathic nephrotic syndrome;Tune;J Am Soc Nephrol,1997

4. Possible therapeutic application of low density lipoprotein apheresis (LDL-A) in conjunction with double filtration plasmapheresis (DFPP) in drug-resistant nephrotic syndrome due to focal glomerular sclerosis (FGS);Tojo;Jpn J Nephrol,1988

5. Treatment with a combination of low-density lipoprotein apheresis and pravastatin of a patient with drug-resistant nephrotic syndrome due to focal segmental glomerulosclerosis;Hattori;Pediatr Nephrol,1993

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rituximab in combination with cyclosporine and steroid pulse therapy for childhood-onset multidrug-resistant nephrotic syndrome: a multicenter single-arm clinical trial (JSKDC11 trial);Clinical and Experimental Nephrology;2023-11-27

2. Proteomics of Plasma and Plasma-Treated Podocytes: Application to Focal and Segmental Glomerulosclerosis;International Journal of Molecular Sciences;2023-07-28

3. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Ninth Special Issue;Journal of Clinical Apheresis;2023-04

4. Long‐term prognosis of focal segmental glomerulosclerosis treated with therapeutic low‐density lipoprotein‐apheresis in patients with severe kidney dysfunction and proteinuria;Rheumatology & Autoimmunity;2023-03

5. Therapeutic Plasmapheresis: a revision of literature.;Kidney and Blood Pressure Research;2022-12-08